Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 146

1.

Factors Associated with Cigarette Use During Airmen's First Year of Service in the United States Air Force.

Little M, Ebbert JO, Krukowski RA, Halbert J, Kalpinski MR, Patten CA, Talcott GW, Klesges RC.

Mil Med. 2019 Jul 9. pii: usz155. doi: 10.1093/milmed/usz155. [Epub ahead of print]

PMID:
31287888
2.

Predicting smokeless tobacco initiation and re-initiation in the United States Air Force.

Dunkle A, Kalpinski R, Ebbert J, Talcott W, Klesges R, Little MA.

Addict Behav Rep. 2018 Nov 8;9:100142. doi: 10.1016/j.abrep.2018.11.001. eCollection 2019 Jun.

3.

Predicting cigarette initiation and reinitiation among active duty United States Air Force recruits.

Little MA, Ebbert JO, Krukowski RA, Halbert JP, Kalpinski R, Patten CA, Boothe TL, Pasker CK, Klesges RC, Talcott GW.

Subst Abus. 2019 Mar 18:1-4. doi: 10.1080/08897077.2019.1577678. [Epub ahead of print]

PMID:
30883297
4.

Influence of gender and peer tobacco use on tobacco use intentions after a period of involuntary tobacco abstinence among U.S. Air Force trainees.

Patten C, Wang XQ, Ebbert JO, Little MA, Talcott GW, Hryshko-Mullen AS, Klesges RC.

Prev Med Rep. 2019 Jan 20;13:270-276. doi: 10.1016/j.pmedr.2019.01.004. eCollection 2019 Mar.

5.

Prevalence and correlates of dual tobacco use in cancer survivors.

Fahey MC, Bursac Z, Ebbert JO, Klesges RC, Little MA.

Cancer Causes Control. 2019 Mar;30(3):217-223. doi: 10.1007/s10552-019-1132-6. Epub 2019 Jan 22.

PMID:
30671688
6.

Correlates of smoking status in cancer survivors.

Little MA, Klesges RC, Bursac Z, Halbert JP, Ebbert J, Talcott GW, Weksler B.

J Cancer Surviv. 2018 Dec;12(6):828-834. doi: 10.1007/s11764-018-0720-x. Epub 2018 Oct 20.

PMID:
30343442
7.

Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.

Hurt RT, Ebbert JO, Croghan IT, Schroeder DR, Hurt RD, Hays JT.

Drug Alcohol Depend. 2018 Mar 1;184:12-17. doi: 10.1016/j.drugalcdep.2017.11.017. Epub 2018 Jan 2.

8.

Controlled Substance Agreements for Opioids in a Primary Care Practice.

Philpot LM, Ramar P, Elrashidi MY, Mwangi R, North F, Ebbert JO.

J Pharm Policy Pract. 2017 Sep 12;10:29. doi: 10.1186/s40545-017-0119-5. eCollection 2017.

9.

Enhancing the efficacy of a smoking quit line in the military: Study rationale, design and methods of the Freedom quit line.

Little MA, Ebbert JO, Bursac Z, Talcott GW, Talley L, LeRoy KM, Womack CR, Hryshko-Mullen AS, Klesges RC.

Contemp Clin Trials. 2017 Aug;59:51-56. doi: 10.1016/j.cct.2017.04.011. Epub 2017 May 4. No abstract available.

10.

Step Care treatment for smoking cessation.

Ebbert JO, Little MA, Klesges RC, Bursac Z, Johnson KC, Thomas F, Vander Weg MW.

Health Educ Res. 2017 Feb 1;32(1):1-11. doi: 10.1093/her/cyw051.

11.

Smokeless tobacco use among United States Air Force trainees.

Linde BD, Ebbert JO, Schroeder DR, Hanson AC, Talcott GW, Klesges RC.

Subst Abus. 2017 Jul-Sep;38(3):278-284. doi: 10.1080/08897077.2016.1275924. Epub 2016 Dec 27.

12.

Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.

Hurt RT, Croghan IT, Schroeder DR, Hays JT, Choi DS, Ebbert JO.

Nicotine Tob Res. 2017 Aug 1;19(8):994-998. doi: 10.1093/ntr/ntw304.

13.

Types of Dual and Poly-Tobacco Users in the US Military.

Little MA, Bursac Z, Derefinko KJ, Ebbert JO, Talcott GW, Hryshko-Mullen A, Klesges RC.

Am J Epidemiol. 2016 Aug 1;184(3):211-8. doi: 10.1093/aje/kwv321. Epub 2016 Jul 15.

14.

Reducing Childhood Tobacco Smoke Exposure.

Ebbert JO, Jacobson RM.

JAMA. 2016 Jun 21;315(23):2610-1. doi: 10.1001/jama.2016.6751. No abstract available.

PMID:
27327803
15.

Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence.

Burke MV, Hays JT, Ebbert JO.

Patient Prefer Adherence. 2016 Apr 1;10:435-41. doi: 10.2147/PPA.S83469. eCollection 2016. Review.

16.

The safety of treatments for tobacco use disorder.

Little MA, Ebbert JO.

Expert Opin Drug Saf. 2016;15(3):333-41. doi: 10.1517/14740338.2016.1131817. Epub 2015 Dec 30. Review.

PMID:
26715118
17.

A Critical Review of Repurposing Apomorphine for Smoking Cessation.

Morales-Rosado JA, Cousin MA, Ebbert JO, Klee EW.

Assay Drug Dev Technol. 2015 Dec;13(10):612-22. doi: 10.1089/adt.2015.680. Review.

PMID:
26690764
18.

Treatment Outcomes From a Specialist Model for Treating Tobacco Use Disorder in a Medical Center.

Burke MV, Ebbert JO, Schroeder DR, McFadden DD, Hays JT.

Medicine (Baltimore). 2015 Nov;94(44):e1903. doi: 10.1097/MD.0000000000001903.

19.

Efficacy of a Brief Tobacco Intervention for Tobacco and Nicotine Containing Product Use in the US Air Force.

Little MA, Talcott GW, Bursac Z, Linde BD, Pagano LA, Messler EC, Ebbert JO, Klesges RC.

Nicotine Tob Res. 2016 May;18(5):1142-9. doi: 10.1093/ntr/ntv242. Epub 2015 Oct 27.

PMID:
26508394
20.

Interventions for smokeless tobacco use cessation.

Ebbert JO, Elrashidi MY, Stead LF.

Cochrane Database Syst Rev. 2015 Oct 26;(10):CD004306. doi: 10.1002/14651858.CD004306.pub5. Review.

PMID:
26501380

Supplemental Content

Loading ...
Support Center